Ubiquitination during infection with Mouse Adenovirus
小鼠腺病毒感染过程中的泛素化
基本信息
- 批准号:10364682
- 负责人:
- 金额:$ 26.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-04 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:Adenovirus InfectionsAdenovirusesAutomobile DrivingCell physiologyCellsComplexCullin ProteinsDNADNA DamageDNA VirusesDataGeneticGoalsHost DefenseHumanInfectionInnate Immune ResponseIntegration Host FactorsInterferonsLATS1 geneLeadLigaseMediatingModelingMolecularMouse ProteinMusNuclearNucleic AcidsOrthologous GenePathway interactionsProcessProductionProteinsProteomeProteomicsRNAReportingResourcesRoleSeminalSignal TransductionSpecies SpecificitySubstrate SpecificitySystemTimeUbiquitinUbiquitinationViralViral PathogenesisViral ProteinsVirusVirus DiseasesYWHAQ genearmbasecellular targetinginnate immune pathwaysinnate immune sensinginsightmembermulticatalytic endopeptidase complexmultidisciplinaryresponsesensorubiquitin ligaseubiquitin-protein ligase
项目摘要
PROJECT SUMMARY
Viruses exert an extensive network of dynamic interactions with host components to promote infection by
dismantling cellular intrinsic and innate defenses. A central arm of viral takeover of cellular processes relies on
viral exploitation of the cellular ubiquitin system to induce degradation of host factors. However, there is a gap
in our understanding of the molecular mechanisms by which ubiquitin is harnessed by viral proteins. Here we
propose a cross-species comparison of the human and mouse adenovirus systems to explore how viruses
subvert host defenses via ubiquitin. Human adenovirus 5 (HAd5) is a prominent nuclear-replicating DNA virus
that redirects cellular Cullin E3 ubiquitin ligase activity via complex formation with two viral early proteins
(E1B55K and E4orf6). We recently developed a proteomics approach to define host proteins ubiquitinated when
the HAd5 E1B55K/E4orf6 complex is expressed. By combining our ubiquitome analysis with whole cell
proteomics, we were able to define which substrates are ubiquitinated and which are subsequently degraded as
a result of the E1B55K/E4orf6 complex. The strict species-specificity of adenovirus infection limits our ability to
study HAd in its natural host, but mouse adenovirus type 1 (MAV-1) provides an alternative tractable system.
Based on genetic similarities, MAV-1 is thought to encode orthologs (mE1B55K and mE4orf6) to the HAd5
complex, and these proteins are presumed to redirect cellular ubiquitin in a parallel fashion. We have applied
our proteomics pipeline to MAV-1 infected cells, and used global ubiquitin-profiling to identify proteins modified
and degraded by the virus. Distinct from HAd5, we discovered that MAV-1 uniquely facilitates degradation of
several canonical and non-canonical proteins involved in nucleic acid sensing and antiviral interferon signaling,
including PKR and STING. Contrary to the prevailing dogma of how the HAd5 E1B55K/E4orf6 complex employs
the E1B55K component to select ubiquitination substrates, we surprisingly discovered that mE4orf6 is sufficient
to reduce abundance of the antiviral RNA sensor PKR in a proteasome- and Cullin- dependent manner,
independent of mE1B55K. These findings collectively suggest divergence in the composition, mechanisms of
assembly, and substrate selectivity between the HAd5 and MAV-1 directed E3 ligases. An overarching
implication is that the MAV-1 and HAd5 complex exploit ubiquitin in different ways to counteract intrinsic and
innate immune responses. In Aim 1 we will leverage a multidisciplinary, quantitative proteomics approach to
systematically define the endogenous cellular ubiquitin substrates and associated pathways targeted during
MAV-1 infection. We will also determine the functional consequences of substrate ubiquitination during infection.
In Aim 2 we will establish the composition, and mechanisms of substrate selection for the MAV-1 directed E3
ligase complex and compare to HAd5. Results of our cross-species comparisons will provide insights into both
core principles and distinct strategies that govern how adenoviruses exploit cellular ubiquitin to dismantle host
defenses and facilitate viral pathogenesis.
项目摘要
病毒与宿主成分建立了广泛的动态相互作用网络,以促进通过
拆除细胞内在和先天防御。病毒接管的中央部门依赖于
细胞泛素系统的病毒开发诱导宿主因子降解。但是,有差距
在我们对泛素通过病毒蛋白利用的分子机制的理解中。我们在这里
提出对人和小鼠腺病毒系统的跨物种比较,以探索病毒的方式
通过泛素颠覆宿主防御。人腺病毒5(HAD5)是一种突出的核重复DNA病毒
这将通过与两个病毒早期蛋白的复合物形成复合形成的细胞库蛋白E3泛素连接酶活性
(E1B55K和E4ORF6)。我们最近开发了一种蛋白质组学方法来定义宿主蛋白泛素化
表达了HAD5 E1B55K/E4ORF6复合物。通过将我们的泛元分析与全细胞结合在一起
蛋白质组学,我们能够定义哪些底物是泛素化的,哪些底物随后降解为
E1B55K/E4ORF6复合物的结果。腺病毒感染的严格物种特异性限制了我们的能力
研究具有天然宿主,但是小鼠腺病毒1型(MAV-1)提供了一种可替代的拖延系统。
基于遗传相似性,MAV-1被认为编码直系同源物(ME1B55K和ME4ORF6)
复合物,这些蛋白质被假定以平行方式重定向细胞泛素。我们已经申请了
我们的蛋白质组学管道到MAV-1感染的细胞,并使用全局泛素促进蛋白来鉴定经过修饰的蛋白质
并因病毒而降解。与HAD5不同,我们发现Mav-1独特地促进了降解
几种参与核酸感应和抗病毒干扰素信号传导的规范和非典型蛋白,
包括PKR和Sting。与HAD5 E1B55K/E4ORF6综合体如何使用的盛行的教条相反
E1B55K组件要选择泛素化底物,我们出人意料地发现ME4ORF6就足够了
为了减少抗病毒RNA传感器PKR的丰度,以蛋白酶体和cullin依赖性方式
独立于ME1B55K。这些发现统称在组成中的分歧,机制
组件和HAD5和MAV-1定向E3连接酶之间的底物选择性。总体
暗示是Mav-1和Mav-1复杂以不同的方式利用泛素来抵消固有和
先天免疫反应。在AIM 1中,我们将利用一种多学科的定量蛋白质组学方法
系统地定义内源性细胞泛素底物和针对性的相关途径
MAV-1感染。我们还将确定感染过程中底物泛素化的功能后果。
在AIM 2中,我们将建立MAV-1指示E3的底物选择的组成和机制
连接酶复合物,与HAD5进行比较。我们的跨物种比较的结果将为两者提供见解
核心原则和不同的策略,这些策略管理腺病毒如何利用细胞泛素来拆除宿主
防御和促进病毒发病机理。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew D. Weitzman其他文献
Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers
将野生型和重组腺相关病毒招募到腺病毒复制中心
- DOI:
- 发表时间:
1996 - 期刊:
- 影响因子:5.4
- 作者:
Matthew D. Weitzman;K. Fisher;James M. Wilson - 通讯作者:
James M. Wilson
A Tribute to Barrie Carter.
向巴里·卡特致敬。
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:4.2
- 作者:
A. Srivastava;Matthew D. Weitzman;S. Chatterjee;J. Engelhardt;R. Owens;Nick Muzyczka;Robin Ali - 通讯作者:
Robin Ali
Live Cell Fluorescence Correlation Spectroscopy with Real Time Photoactivation Feedback
- DOI:
10.1016/j.bpj.2012.11.3181 - 发表时间:
2013-01-29 - 期刊:
- 影响因子:
- 作者:
Matthew D. Weitzman;Chandran R. Sabanayagam;Kenneth L. van Golen - 通讯作者:
Kenneth L. van Golen
Interaction of wild-type and mutant adeno-associated virus (AAV) Rep proteins on AAV hairpin DNA
野生型和突变型腺相关病毒 (AAV) Rep 蛋白在 AAV 发夹 DNA 上的相互作用
- DOI:
- 发表时间:
1996 - 期刊:
- 影响因子:5.4
- 作者:
Matthew D. Weitzman;S. R. Kyöstiö;Barrie J. Carter;R. Owens - 通讯作者:
R. Owens
Matthew D. Weitzman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew D. Weitzman', 18)}}的其他基金
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10448505 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
Ubiquitination during infection with Mouse Adenovirus
小鼠腺病毒感染过程中的泛素化
- 批准号:
10152932 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
Non-canonical chimeric proteins generated during Adenovirus infection
腺病毒感染期间产生的非典型嵌合蛋白
- 批准号:
10312411 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
Double-stranded RNA during DNA virus infection
DNA病毒感染期间的双链RNA
- 批准号:
9886201 - 财政年份:2019
- 资助金额:
$ 26.4万 - 项目类别:
Double-stranded RNA during DNA virus infection
DNA病毒感染期间的双链RNA
- 批准号:
10092100 - 财政年份:2019
- 资助金额:
$ 26.4万 - 项目类别:
Double-stranded RNA during DNA virus infection
DNA病毒感染期间的双链RNA
- 批准号:
10359055 - 财政年份:2019
- 资助金额:
$ 26.4万 - 项目类别:
Double-stranded RNA during DNA virus infection
DNA病毒感染期间的双链RNA
- 批准号:
9764127 - 财政年份:2019
- 资助金额:
$ 26.4万 - 项目类别:
Double-stranded RNA during DNA virus infection
DNA病毒感染期间的双链RNA
- 批准号:
10571919 - 财政年份:2019
- 资助金额:
$ 26.4万 - 项目类别:
Adenovirus manipulation of cellular chromatin to overcome host responses
腺病毒操纵细胞染色质以克服宿主反应
- 批准号:
10238103 - 财政年份:2018
- 资助金额:
$ 26.4万 - 项目类别:
Adenovirus manipulation of cellular chromatin to overcome host responses
腺病毒操纵细胞染色质以克服宿主反应
- 批准号:
9979734 - 财政年份:2018
- 资助金额:
$ 26.4万 - 项目类别:
相似国自然基金
肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
- 批准号:82303776
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PD-1/PD-L1信号促CD21-B细胞BCR髓外二次编辑降低自身反应性在儿童腺病毒肺炎中的作用机制研究
- 批准号:82370015
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
- 批准号:82302607
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
禽腺病毒血清11型反向遗传平台的建立与毒株间致病性差异机制探究
- 批准号:32372997
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CD46和DSG2双受体在人B组腺病毒感染与致病中的协同作用和机制研究
- 批准号:32370155
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Ubiquitination during infection with Mouse Adenovirus
小鼠腺病毒感染过程中的泛素化
- 批准号:
10152932 - 财政年份:2021
- 资助金额:
$ 26.4万 - 项目类别:
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma
一种新型腺病毒许可、免疫功能正常的仓鼠模型,用于评估胶质母细胞瘤的溶瘤腺病毒治疗
- 批准号:
10593081 - 财政年份:2020
- 资助金额:
$ 26.4万 - 项目类别:
A Novel Adenoviral-Permissive, Immunocompetent Hamster Model to Evaluate Oncolytic Adenoviral Therapy for Glioblastoma
一种新型腺病毒许可、免疫功能正常的仓鼠模型,用于评估胶质母细胞瘤的溶瘤腺病毒治疗
- 批准号:
10373942 - 财政年份:2020
- 资助金额:
$ 26.4万 - 项目类别:
Papillomavirus Proteins Mediating Cancer and Senescence
介导癌症和衰老的乳头瘤病毒蛋白
- 批准号:
7188105 - 财政年份:2004
- 资助金额:
$ 26.4万 - 项目类别: